Bide Pharmatech Securities Affairs Representative Chen Yili Resigns for Personal Reasons

财中社··CN·Read original
1▲0 ▼0Impact / 5
Summary · why it matters

Bide Pharmatech announced on October 8 that Chen Yili has applied to resign as securities affairs representative for personal reasons and will no longer hold any position at the company. In the first half of 2026, Bide Pharmatech achieved revenue of 683 million yuan and net profit attributable to the parent of 103 million yuan.

Impact on assets 1

Others▲